Abstract:Use of novel modulators targeting P-glycoprotein (P-gp, ABCB1 transporter) is among the most accepted strategies for overcoming multidrug resistance in cancer chemotherapy. In the current study, we pursued our structure-activity relationship studies of jatrophane derivatives by structural modification of compound 1, a natural jatrophane isolated from Euphorbia. sororia A. Nine compounds exhibited higher reversal activity in P-gp/ABCB1-mediated MCF-7/ADR cells than verapamil (VRP). The cytotoxicity and doxorubicin (DOX) intracellular accumulation effects of jatrophane derivatives were assessed in normal HEK293T cells and DOX-resistant MCF-7/ADR cells. The most potent compound 17 merits multiple activities, including (1) high efficiency (EC50 = 182.17 ± 32.67 nM) in reversing P-gp-mediated resistance to DOX, low cytotoxicity, and a high therapeutic index; and (2) increasing the accumulation of Rhodamine123 (Rho123) and DOX in a dose-dependent manner compared to verapamil in MCF-7/ADR cells. Our results indicated that the reversal activity of 17 was due to the stimulation of the P-gp ATPase activity instead of the direct inhibition of P-gp protein expression. A docking study demonstrated that 17 has a high binding affinity toward the DOX recognition site of P-gp. This resulted in 17 enhancing the sensitivity of DOX to MCF-7/ADR cells by stimulating P-gp ATPase activity, increasing intracellular DOX and Rho123 concentrations, inhibiting the phosphoinositide 3-kinase/serine-threonine kinase mediated by DOX and further reducing the expression of P-gp. This study provides a promising P-gp inhibitor for reversing multidrug resistance and provides a basis for further research.

O2-(2,4-dinitrophenyl)diazeniumdiolates Derivatives: Design, Synthesis, Cytotoxic Evaluation and Reversing MDR in MCF-7/ADR Cells.

Design and Synthesis of New Hybrids from 2-Cyano-3,12-dioxooleana- 9-Dien-28-oic Acid and O2-(2,4-dinitrophenyl) Diazeniumdiolate for Intervention of Drug-Resistant Lung Cancer.

Development of Oxoisoaporphine Derivatives with Topoisomerase I Inhibition and Reversal of Multidrug Resistance in Breast Cancer MCF-7/ADR Cells.

Synthesis and Evaluation of Nitric Oxide-Releasing DDB Derivatives As Potential Pgp-mediated MDR Reversal Agents in MCF-7/Adr Cells.

Hybrid Molecule from O2-(2,4-Dinitrophenyl)diazeniumdiolate and Oleanolic Acid: A Glutathione S-Transferase Π-Activated Nitric Oxide Prodrug with Selective Anti-Human Hepatocellular Carcinoma Activity and Improved Stability

Nitric Oxide Prodrugs And Metallochemotherapeutics: Js-K And Cb-3-100 Enhance Arsenic And Cisplatin Cytolethality By Increasing Cellular Accumulation

Design, Synthesis, and Evaluation of Diazeniumdiolate-Based DNA Cross-Linking Agents Activatable by Glutathione S-Transferase.

Synthesis and Evaluation of Furoxan-Based Nitric Oxide-Releasing Derivatives of Tetrahydroisoquinoline As Anticancer and Multidrug Resistance Reversal Agents

Discovery and Synthesis of Sulfur-Containing 6-Substituted 5,8-Dimethoxy-1,4-naphthoquinone Oxime Derivatives As New and Potential Anti-Mdr Cancer Agents.

Design, Synthesis and Multidrug Resistance Reversal Activity Evaluation of 8-Oxocoptisine Derivatives

Novel Anticancer Oridonin Derivatives Possessing a Diazen-1-ium-1,2-diolate Nitric Oxide Donor Moiety: Design, Synthesis, Biological Evaluation and Nitric Oxide Release Studies.

Seco-4-methyl-DCK Derivatives As Potent Chemosensitizers

Design, Synthesis and Biological Evaluation of Novel O-2-(2,4-Dinitrophenyl) diazeniumdiolates as Anti-tumor Agents

Potent Inhibition of Nitric Oxide-Releasing Bifendate Derivatives Against Drug-Resistant K562/A02 Cells in Vitro and in Vivo.

Sphorodiamidate Mustard-Based O 2-Phosphorylated Diazeniumdiolates with Potent Anticancer Activity †

O2-(6-Oxocyclohex-1-en-1-yl)methyl Diazen-1-ium-1,2-diolates: a New Class of Nitric Oxide Donors Activatable by GSH/GST with Both Anti-Proliferative and Anti-Metastatic Activities Against Melanoma (vol 53, Pg 5059, 2017)

Synthesis of Cddo-Amino Acid-Nitric Oxide Donor Trihybrids As Potential Antitumor Agents Against Both Drug-Sensitive and Drug-Resistant Colon Cancer

Novel Nitric Oxide-Releasing Spirolactone-Type Diterpenoid Derivatives with in Vitro Synergistic Anticancer Activity As Apoptosis Inducer

Discovery of a Novel Highly Potent and Low-Toxic Jatrophane Derivative Enhancing the P-glycoprotein-mediated Doxorubicin Sensitivity of MCF-7/ADR Cells.

Development of Novel Amino-Quinoline-5,8-dione Derivatives As NAD(P)H:quinone Oxidoreductase 1 (NQO1) Inhibitors with Potent Antiproliferative Activities

Nobiletin and its derivatives overcome multidrug resistance (MDR) in cancer: total synthesis and discovery of potent MDR reversal agents